ALYSE M SNIDER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner BOWLING GREEN, OH NPI 1548645203

General Payments — all program years on this page

$933.25

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $353.17 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $353.1720

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $223.3813
ABBVIE INC. $36.982
Axsome Therapeutics, Inc. $36.292
Exact Sciences Corporation $34.522
Lilly USA, LLC $22.001

By program year

Program yearAmountRecords
2021 $66.061
2022 $173.835
2023 $340.1911
2024 $353.1720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100275474 Novo Nordisk Inc $12.45 08/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100336344 Novo Nordisk Inc $5.97 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100352788 Novo Nordisk Inc $12.40 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100365917 Novo Nordisk Inc $11.48 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100393416 Novo Nordisk Inc $72.61 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100470036 Novo Nordisk Inc $13.35 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100490411 Novo Nordisk Inc $7.78 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100509969 Novo Nordisk Inc $12.00 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100574976 Novo Nordisk Inc $14.79 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100585134 Novo Nordisk Inc $14.29 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100601847 Novo Nordisk Inc $15.25 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100603440 Novo Nordisk Inc $14.70 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100626712 Novo Nordisk Inc $16.31 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108226507 ABBVIE INC. $21.03 06/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108226509 ABBVIE INC. $15.95 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114523868 Exact Sciences Corporation $16.16 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114523873 Exact Sciences Corporation $18.36 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135498262 Lilly USA, LLC $22.00 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148332135 Axsome Therapeutics, Inc. $14.49 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148332137 Axsome Therapeutics, Inc. $21.80 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.